We respectfully disagree with Judge Gergel’s rulings and believe there is a strong association between Lipitor and Type 2 diabetes. Read more
The U.S. Food and Drug Administration (FDA) has strengthened its warning for Invokana (canagliflozin, Invokamet, Johnson & Johnson/Janssen Pharmaceuticals Inc.) related to the increased... Read more
Lawyers in our firm are continuously being asked about what all our Mass Torts Section is doing. So we will again give an update on activity in the section. Lawyers in the Section will inves... Read more
As we mentioned above, lawyers in the Mass Torts Section at Beasley Allen continue to evaluate and file claims involving bladder cancer during or following usage of Actos, Actoplus Met, Acto... Read more
U.S. District Judge Rebecca Doherty has rejected the attempt by Takeda Pharmaceutical Co. and Eli Lilly & Co. to get the combined $9 billion punitive-damage award returned by a jury thro... Read more
Lipitor, one of the best-selling prescription drugs of all time, causes Type 2 Diabetes. Post-menopausal women appear to be at greatest risk. The link between Lipitor and diabetes has been... Read more
A federal jury in Lafayette, La., last month ordered Takeda Pharmaceutical Co., based in Osaka, Japan, and its partner, Eli Lilly & Co, based in Indianapolis, Ind., to pay a combined $9... Read more
Beasley Allen lawyers continue to pursue Actos claims on behalf of individuals who have been diagnosed with bladder cancer after using Actos to treat their type 2 diabetes. Andy Birchfield a... Read more
Four popular diabetes drugs are rapidly gaining critical notoriety in the United States. Januvia (Merck), Janumet (Merck), Byetta (Amylin / Bristol-Myers Squibb) and Victoza (Norvo Nordisk)... Read more
Our firm recently filed suit against the manufacturers of two popular medications used to treat Type 2 Diabetes Mellitus, Januvia and Byetta. Januvia (sitagliptin phosphate) is an oral medic... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.